Laura Roca-Alonso
Chief Operating Officer en E-THERAPEUTICS PLC .
Origen de la red de primer grado Laura Roca-Alonso.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 48 | |
| Public Company | Biotechnology | 10 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Laura Roca-Alonso a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| SAREUM HOLDINGS PLC | Miscellaneous | Chairman Director/Board Member | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chairman Chairman | |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chairman Director/Board Member President Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Corporate Officer/Principal Masters Business Admin Graduate Degree | |
| MEDIGENE AG | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| FEEDBACK PLC | Packaged Software | Chairman Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
PA Consulting Group Ltd.
 PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Manchester | College/University | Doctorate Degree Doctorate Degree | |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Masters Business Admin Graduate Degree | |
Lonza Biologics Plc
 Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
| University of London | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| The University of Edinburgh | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University College Dublin | College/University | Undergraduate Degree Undergraduate Degree | |
Cambridge Biotechnology Ltd.
 Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Biotechnology Ltd. is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class 'gene to lead' drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area. CBT is always looking to identify potential partner companies for both in-licensing and risk-sharing drug discovery ventures. | Miscellaneous Commercial Services | Founder Chief Executive Officer | |
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| University College London | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Summit (Cambridge) Ltd.
 Summit (Cambridge) Ltd. Pharmaceuticals: MajorHealth Technology Summit (Cambridge) Ltd. develops and manufactures drugs and pharmaceuticals. It discovers and develops therapeutics for neurological, ophthalmologic, metabolic, and gastrointestinal diseases. The company was founded in 2001 by Paul Goldsmith and Mark Carlton and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| UK Stem Cell Foundation | Investment Trusts/Mutual Funds | Founder Founder | |
| King's College London | College/University | Corporate Officer/Principal Doctorate Degree | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
Sareum Ltd.
 Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Drugstore Chains | Director/Board Member Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Medical/Nursing Services | Director of Finance/CFO Chief Executive Officer | |
Boehringer Ingelheim BV
 Boehringer Ingelheim BV Drugstore ChainsRetail Trade An international, innovative, pharmaceutical, family business Boehringer Ingelheim BV is an international, innovative pharmaceutical company that focuses on the development and marketing of new drugs that help improve the health and welfare of humans and animals. The company was established in 1945 and is headquartered in Alkmaar, the Netherlands. | Drugstore Chains | Corporate Officer/Principal | |
The Institute of Directors (United Kingdom)
 The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Singer Capital Markets Securities Ltd.
 Singer Capital Markets Securities Ltd. Investment Banks/BrokersFinance Part of N1 Singer Ltd., Singer Capital Markets Securities Ltd. is a brokerage firm. The private company is based in London, UK. The British company was founded in 2012 by Timothy Bruce Cockroft, Peter Welch. Timothy Bruce Cockroft has been the CEO since 2012. | Investment Banks/Brokers | Analyst-Equity | |
| ARIX BIOSCIENCE PLC | Investment Managers | Director/Board Member Director/Board Member | |
| NUFORMIX PLC | Biotechnology | Chairman Director/Board Member | |
| SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman Public Communications Contact | |
| PREMIER VETERINARY GROUP PLC | Agricultural Commodities/Milling | Chairman Comptroller/Controller/Auditor | |
| CHILL BRANDS GROUP PLC | Pharmaceuticals: Other | Founder Founder |
Estadísticas
Internacional
| Reino Unido | 31 |
| Estados Unidos | 10 |
| Alemania | 4 |
| Países Bajos | 3 |
| Suiza | 2 |
Sectorial
| Health Technology | 24 |
| Consumer Services | 11 |
| Commercial Services | 8 |
| Finance | 4 |
| Miscellaneous | 3 |
Operativa
| Director/Board Member | 401 |
| Corporate Officer/Principal | 129 |
| Chairman | 123 |
| Independent Dir/Board Member | 82 |
| Chief Executive Officer | 71 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| Annalisa Jenkins | 51 |
| David C. U'Prichard | 49 |
| James Topper | 49 |
| Andrew Richards | 44 |
| Iain Ross | 41 |
| Trevor Jones | 36 |
| Michael Bretherton | 33 |
| Stephen Parker | 32 |
| Stuart J. M. Collinson | 25 |
| Alastair Riddell | 24 |
| David Solomon | 22 |
| David Lemus | 22 |
| Simon Sturge | 20 |
| David Mack | 19 |
- Bolsa de valores
- Insiders
- Laura Roca-Alonso
- Conexiones Empresas
